MALDI Imaging Mass Spectrometry for Small Molecule Binding Distribution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack the capability to detect the presence or absence and measure the distribution state of small molecules like voacangine in cells or biosamples, particularly in relation to their binding with target proteins, which is crucial for determining angiogenesis inhibition.
Innovation Solution
A method utilizing MALDI mass spectrometry to detect and measure the binding distribution of small molecules with target proteins by comparing MALDI mass spectrometry results with immunofluorescence data, specifically identifying peaks and concentrations associated with voacangine and its fragments, and determining angiogenesis inhibition based on these measurements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used, then the detection process is simple, but the capability to detect small molecule presence and distribution in cells is insufficient
Solution Approach 1:
The patent combines MALDI mass spectrometry with immunofluorescence microscopy to create a dual-detection system. The MALDI-MS provides small molecule detection with mass spectral information, while immunofluorescence provides protein localization data. By merging these two techniques and overlaying their respective images, the system achieves comprehensive detection of small molecule presence, distribution, and binding to target proteins, resolving the limitation of conventional single-method detection.
2Loss of information
If MALDI mass spectrometry is used to detect small molecules, then the distribution state can be measured, but the complexity of the detection method increases
Solution Approach 1:
The MALDI mass spectrometry system is configured to perform multiple functions: detecting small molecule presence through mass spectral peaks, measuring spatial distribution through imaging capability, and identifying target protein binding through co-localization analysis with immunofluorescence data. This multi-functional approach allows a single detection platform to provide comprehensive information about small molecule behavior in biological samples, reducing the need for multiple separate assays.
3Measurement precision
If immunofluorescence is used alone, then the target protein can be detected, but the small molecule binding distribution cannot be determined
Solution Approach 1:
The patent uses image overlay and correlation analysis as an intermediary process to connect MALDI-MS small molecule detection data with immunofluorescence protein localization data. By spatially aligning and comparing the two datasets, the system determines whether small molecules bind to target proteins and measures the distribution of these binding events, providing quantitative binding information without requiring direct physical interaction between the detection methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise detection and measurement of small molecule distribution and binding with target proteins, effectively determining angiogenesis inhibition, with MALDI mass spectrometry providing detailed insights into the presence and effect of voacangine in biotissues with high spatial resolution.
Implementation Method 1
The histology-directed Matrix-Assisted Laser Desorption Ionization (MALDI) imaging mass spectrometry developed by Richard M. Caprioli is an imaging mass spectrometry using MALDI, obtaining mass spectrometry information directly from a tissue through MALDI by coating a matrix on the surface of the tissue which is to be inspected.
Implementation Method 2
detecting a target protein for the drug in the prepared sample by immunofluorescence
Data Source
AI summary
Disclosed is a angiogenesis inhibition determining method using MALDI mass spectrometry, and more particularly, relate to a method for detecting whether small molecules are bound with a target protein and for measuring a binding distribution between the small molecules and the target protein by comparing a result of MALDI mass spectrometry with a result of immunofluorescence of the small molecules, which are used as drugs, for the target protein, and for determining as angiogenesis is inhibited in a portion overlapping with a portion where the drug small molecules are present after the MALDI mass spectrometry in the cell or in the biosample including organelles and a portion where the target protein is present after immunofluorescence, as well as for detecting presence or absence and a distribution state of small molecules used as drugs in a sample by using MALDI mass spectrometry.